process

Tumor Microenvironment

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Tumor Microenvironment: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

568Connections

0Hypotheses

0Analyses

38Outgoing

50Incoming

0Experiments

0Debates

No summary available yet.

View on Wiki →

No AI portrait yet

🧬 Biological Process Info

Name	Tumor Microenvironment
Key Genes/Proteins	ADSL, AGING, AKT, ALZHEIMER, AMPK, AMYOTROPHIC LATERAL SCLEROSIS
Related Diseases	Aging, Als, Alzheimer, Alzheimer'S Disease, Amyotrophic Lateral Sclerosis

Pathway Diagram

graph TD
    Tumor_Microenvironment["Tumor Microenvironment"]
    Glioblastoma_Invasion["Glioblastoma Invasion"]
    Tumor_Microenvironment -->|"modulates"| Glioblastoma_Invasion
    Tumor{"Tumor"}
    Tumor -.->|"inhibits"| Tumor_Microenvironment
    Cancer{"Cancer"}
    Cancer -.->|"inhibits"| Tumor_Microenvironment
    Als{"Als"}
    Als -->|"therapeutic_target"| Tumor_Microenvironment
    CANCER(["CANCER"])
    CANCER -->|"activates"| Tumor_Microenvironment
    style Tumor_Microenvironment fill:#1a3a4a,stroke:#90a4ae,stroke-width:3px,color:#e0e0e0

Outgoing (38)

Target	Relation	Type	Str
Stimuli-Responsive Nanoplatforms	interacts_with	compound	0.90
Brain Metastasis	contributes_to	disease	0.90
Cancer Immunotherapy Resistance	contributes_to	phenotype	0.85
Clear Cell Renal Carcinoma	involved_in	disease	0.85
Endometriosis-Associated Ovarian Cancer	contributes_to	disease	0.80
Endometriosis-Associated Ovarian Cancer	involved_in	disease	0.80
Glioblastoma Invasion	modulates	phenotype	0.80
Papillary Thyroid Carcinoma	involved_in	disease	0.80
STAT1	regulates	gene	0.65
CISPLATIN	activates	drug	0.65
LACTATE	interacts_with	phenotype	0.65
Immunotherapy	inhibits	process	0.50
Immunotherapy	associated_with	process	0.50
FIBROBLASTS	interacts_with	concept	0.50
FIBROBLASTS	activates	concept	0.50
Immunotherapy	activates	process	0.50
CYTOKINE	regulates	concept	0.50
Gastric Cancer	interacts_with	disease	0.50
STING PATHWAY	associated_with	pathway	0.50
EXTRACELLULAR VESICLES	activates	concept	0.50
Epithelial-Mesenchymal Transition	activates	process	0.50
STEM CELLS	interacts_with	concept	0.50
Immunotherapy	interacts_with	process	0.50
Fatty Liver	activates	disease	0.50
Melanoma	associated_with	disease	0.50
CYTOKINE	activates	concept	0.50
DENDRITIC CELLS	regulates	concept	0.50
Proteins	interacts_with	protein	0.50
Pancreatic Cancer	interacts_with	disease	0.50
Immune Checkpoint	inhibits	pathway	0.50
PD-1/PD-L1	inhibits	concept	0.50
PD-L1	inhibits	concept	0.50
CELL MIGRATION	activates	concept	0.50
NICOTINAMIDE	associated_with	drug	0.45
EXOSOME	associated_with	organelle	0.45
OSIMERTINIB	associated_with	drug	0.45
NOTCH SIGNALING	associated_with	pathway	0.45
CISPLATIN	associated_with	drug	0.45

Incoming (530)

Source	Relation	Type	Str
Als	associated_with	disease	1.00
Carcinoma	activates	disease	1.00
Als	regulates	disease	1.00
Cancer	activates	disease	1.00
Tumor	activates	disease	1.00
CANCER	therapeutic_target	gene	1.00
Cancer	therapeutic_target	disease	1.00
Colorectal Cancer	activates	disease	1.00
Cancer	inhibits	disease	1.00
Cancer	associated_with	disease	1.00
Tumor	inhibits	disease	1.00
Als	therapeutic_target	disease	1.00
Tumor	therapeutic_target	disease	1.00
CANCER	activates	gene	1.00
APOPTOSIS	therapeutic_target	gene	1.00
CANCER	associated_with	gene	1.00
Tumor	associated_with	disease	1.00
AKT	therapeutic_target	gene	1.00
Carcinoma	therapeutic_target	disease	1.00
ROS	activates	gene	1.00
GENES	therapeutic_target	gene	1.00
Cancer	regulates	disease	1.00
CANCER	regulates	gene	1.00
Tumor	regulates	disease	1.00
Colorectal Cancer	therapeutic_target	disease	1.00
OVERVIEW	therapeutic_target	gene	1.00
Als	activates	disease	1.00
DNA	regulates	gene	1.00
Als	treats	disease	1.00
STAT3	activates	gene	1.00
Tumor	interacts_with	disease	1.00
Inflammation	therapeutic_target	disease	1.00
CANCER	inhibits	gene	1.00
NF-ΚB	activates	gene	1.00
INFLAMMATION	activates	gene	1.00
PI3K	therapeutic_target	gene	1.00
Inflammation	activates	disease	1.00
DNA	therapeutic_target	gene	1.00
MTOR	therapeutic_target	gene	1.00
INFLAMMATION	therapeutic_target	gene	1.00
Glutathione	associated_with	compound	0.95
IL-6	modulates	protein	0.95
extracellular vesicles	promotes	process	0.92
Myeloid Cells	involved_in	cell_type	0.90
T Cells	involved_in	cell_type	0.90
Lung Adenocarcinoma	involved_in	disease	0.90
Complement Proteins	involved_in	protein	0.90
Extracellular Vesicles	modulates	process	0.90
Lung Adenocarcinoma	associated_with	disease	0.90
IL-6 family	modulates	cytokine	0.90

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning Tumor Microenvironment in their description or question text

No additional research found